pentobarbital has been researched along with Disease Exacerbation in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentobarbital sodium coma is a second-tier treatment that can be used to treat RICH." | 6.42 | Pentobarbital sodium coma for refractory intracranial hypertension. ( Censullo, JL; Sebastian, S, 2003) |
| "Pentobarbital sodium coma is a second-tier treatment that can be used to treat RICH." | 2.42 | Pentobarbital sodium coma for refractory intracranial hypertension. ( Censullo, JL; Sebastian, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Censullo, JL | 1 |
| Sebastian, S | 1 |
1 review available for pentobarbital and Disease Exacerbation
| Article | Year |
|---|---|
Pentobarbital sodium coma for refractory intracranial hypertension.
Topics: Critical Care; Disease Progression; Drug Monitoring; Electroencephalography; Humans; Hypnotics and S | 2003 |